The formation of blood clots is the cause of the different (and often fatal) diseases. Of course, there are means of treatment of thrombosis, but in permanent employment, they have one very unpleasant property: the development of bleeding. To take the vaccine, developed by scientists from the University of Osaka (Japan). The vaccine may be used not only as prevention of disease development, but also as a means to protect against recurrence of the previously migrated diseases.
The new vaccine has the working title of S100A9 and she had already undergone a series of successful experiments on mice. It turned out that it provides protection from blood clots for more than two months from the date of production. In addition, the vaccine does not cause autoimmune reactions and does not increase the risk of bleeding. Such a long period is really a real breakthrough. As stated by one of the study’s authors, Dr. Hironori Nakagami,
“Many stroke patients should take medication daily. And sometimes they simply forget or get tired of doing it. What increases the risk of recurrent stroke. Our vaccine may one day help to solve this problem.”
During the experiments, the vaccine S100A9 was compared with the one of the most common treatment to prevent blood clots with clopidogrel. It turned out that the vaccine has the same effectiveness as an anticoagulant. But scientists themselves caution expressed about the future of their development.
“We are continuing our testing and hope for a full clinical trial. But it is important to understand that in humans and mice there are many differences in the body. And we can’t be sure, as the immune system and other person will react to a promising vaccine.”
This and other news you can discuss in our chat in Telegram.